- Recent Funding
- Investors
- BrightGene
BrightGene portfolio
BrightGene has 1 portfolio company on record at Recent Funding.
About this page
Its most recent investment on record is Citryll's $20.88M Series B+ round in July 2020, alongside ModiQuest B.V., Seventure Partners, BOM and 1 other. That company is in Health and bio.
What BrightGene invests in
- Health and bio · 1 · 100%
How BrightGene invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 1 100% | $20.88M |
BrightGene portfolio companies
| Company | Round with BrightGene | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $20.88M | $113.38M | Dec 9, 2024 Series B+ |
Most frequent co-investors
- MModiQuest B.V.1 shared round · last Jul 2, 2020
SSeventure Partners1 shared round · last Jul 2, 2020
BBOM1 shared round · last Jul 2, 2020
BBioGeneration Ventures1 shared round · last Jul 2, 2020
Similar investors
AAvant Bio1 company · 1 deal in 12 mo
BBiospring Partners1 company · 1 deal in 12 mo
CColossa Ventures1 company · 1 deal in 12 moCCommerzbank1 company · 1 deal in 12 mo
CCultivian Sandbox Ventures1 company · 1 deal in 12 mo
FFiducia1 company · 1 deal in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 1 round on Recent Funding that name BrightGene. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists BrightGene, which is a subset of its real portfolio. API: /api/v1/investors/brightgene (get a free API key). More: the most active VC firms and new venture capital funds.